INSM INSMED Inc

Price (delayed)

$35.77

Market cap

$3.69B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$3.01

Enterprise value

$3.56B

Sector: Healthcare
Industry: Biotechnology

Highlights

The equity is down by 23% from the previous quarter but it is up by 5% YoY
INSM's revenue is up by 20% year-on-year but it is down by 2.5% since the previous quarter
The company's quick ratio fell by 36% QoQ and by 22% YoY
INSMED's net income has decreased by 20% QoQ and by 16% YoY

Key stats

What are the main financial stats of INSM
Market
Shares outstanding
103.04M
Market cap
$3.69B
Enterprise value
$3.56B
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
13.21
Price to sales (P/S)
21.24
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
21.64
Earnings
Revenue
$164.41M
EBIT
-$263.12M
EBITDA
-$248.97M
Free cash flow
-$225.59M
Per share
EPS
-$3.01
Free cash flow per share
-$2.31
Book value per share
$2.71
Revenue per share
$1.68
TBVPS
$7.65
Balance sheet
Total assets
$796.16M
Total liabilities
$520.27M
Debt
$404.84M
Equity
$275.88M
Working capital
$504.09M
Liquidity
Debt to equity
1.47
Current ratio
5.24
Quick ratio
4.62
Net debt/EBITDA
0.51
Margins
EBITDA margin
-151.4%
Gross margin
75.7%
Net margin
-178.9%
Operating margin
-161.3%
Efficiency
Return on assets
-36.8%
Return on equity
-94.5%
Return on invested capital
-51.3%
Return on capital employed
-38.8%
Return on sales
-160%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

INSM stock price

How has the INSMED stock price performed over time
Intraday
-3.74%
1 week
-12.54%
1 month
-15.34%
1 year
35.9%
YTD
7.45%
QTD
7.45%

Financial performance

How have INSMED's revenue and profit performed over time
Revenue
$164.41M
Gross profit
$124.54M
Operating income
-$265.23M
Net income
-$294.09M
Gross margin
75.7%
Net margin
-178.9%
INSMED's operating margin has decreased by 25% from the previous quarter but it has increased by 6% YoY
The net margin has contracted by 23% from the previous quarter but it has grown by 4% YoY
INSMED's operating income has decreased by 22% QoQ and by 13% YoY
INSM's revenue is up by 20% year-on-year but it is down by 2.5% since the previous quarter

Growth

What is INSMED's growth rate over time

Valuation

What is INSMED stock price valuation
P/E
N/A
P/B
13.21
P/S
21.24
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
21.64
The EPS has declined by 16% since the previous quarter
The price to book (P/B) is 94% higher than the 5-year quarterly average of 6.8 and 54% higher than the last 4 quarters average of 8.6
The equity is down by 23% from the previous quarter but it is up by 5% YoY
INSM's price to sales (P/S) is 31% higher than its last 4 quarters average of 16.2
INSM's revenue is up by 20% year-on-year but it is down by 2.5% since the previous quarter

Efficiency

How efficient is INSMED business performance
The ROS has declined by 26% since the previous quarter but it has grown by 3.3% year-on-year
The ROIC has declined by 24% since the previous quarter
INSM's ROE is down by 19% from the previous quarter
The company's return on assets fell by 18% QoQ and by 5% YoY

Dividends

What is INSM's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for INSM.

Financial health

How did INSMED financials performed over time
INSM's total assets is 53% higher than its total liabilities
The company's quick ratio fell by 36% QoQ and by 22% YoY
The current ratio has contracted by 34% from the previous quarter and by 20% YoY
The debt is 47% more than the equity
The debt to equity is up by 31% from the previous quarter but it is down by 3.3% YoY
The equity is down by 23% from the previous quarter but it is up by 5% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.